HONG KONG, Aug. 21, 2014
/PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) (the
"Company") today announced its plan to release financial results
for the first quarter of fiscal year 2015 on Thursday, August 28, 2014, after market close in
the US.
The Company will host a conference call at 8:00 a.m. ET on Friday,
August 29, 2014 to discuss its financial performance and
give a brief overview of the Company's recent developments,
followed by a question and answer session. Interested parties
may access the audio webcast through the Company's IR website at
http://ir.chinacordbloodcorp.com. A replay of the webcast
will be accessible two hours after the conference call and
available for three weeks at the same URL link above.
Listeners may also access the call by dialing 1-631-514-2526 or
1-855-298-3404 for US callers or +852-5808-3202 for Hong Kong callers, access code:
1856118.
Please dial in ten minutes prior to the conference call to
ensure proper connection, and be prepared to provide your name and
company name to the operator.
Supplemental financial information referenced in the conference
call and the first quarter of fiscal 2015 earnings press release
will be available at http://www.chinacordbloodcorp.com, in the
section titled Investor Center/Press Release, after 4:00 p.m. ET on Thursday,
August 28, 2014 and in the Company's Report on Form 6-K for
the month of August 2014 available on
the Securities and Exchange Commission's website at www.sec.gov.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical
cord blood banking operator in China in terms of geographical coverage and
the only cord blood banking operator with multiple licenses.
Under current PRC government regulations, only one licensed cord
blood banking operator is permitted to operate in each licensed
region and only seven licenses have been authorized as of today.
China Cord Blood Corporation provides cord blood collection,
laboratory testing, hematopoietic stem cell processing and stem
cell storage services. For more information, please visit the
Company's website at http://www.chinacordbloodcorp.com.
For more information, please contact:
China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com
ICR, Inc.
Mr. William Zima
Tel: (+86) 10-6583-7511
U.S. Tel: (646) 405-5185
Email: william.zima@icrinc.com
SOURCE China Cord Blood Corporation